Status:
UNKNOWN
Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy
Lead Sponsor:
Asan Medical Center
Collaborating Sponsors:
Astellas Pharma Inc
Conditions:
Prostatic Neoplasms, Prostatectomy
Eligibility:
MALE
Phase:
NA
Brief Summary
To date, there is a lack of consensus concerning the optimal timing for removal of the urethral catheter, its related complications, the effectiveness in prophylactic drug use to reduce complication, ...
Eligibility Criteria
Inclusion
- Patients must have localized or locally advanced prostate cancer
- Patients must receive robot assisted laparoscopic radical prostatectomy
- Patients must be able to provide written informed consent
Exclusion
- Patients must not have a history of treatment with alpha blockers within 4 weeks
- Patients must not have previously undergone transurethral resection, laser therapy, or other surgery of the prostate
- Patients must not have previously been diagnosed with neurogenic bladder
- Patients must not have hypersensitivity to trial drug or other alpha-blockers
- Patients must not have the participation of other clinical trial within the past 3 months
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT01209988
Start Date
April 1 2010
End Date
December 1 2011
Last Update
September 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736